PhD

Dr Quintana is a Professor of Neurology in the Ann Romney Center for Neurologic Diseases at the Brigham and Women’s Hospital, Harvard University and an Associate Member at the Broad Institute. His research investigates signaling pathways that control immune response and neuro-degeneration with the goal of identifying novel targets and biomarkers for immune-mediated disorders. His work identified an important role for the AHR transcription factor in control of inflammation driven by adaptive and innate immune cells, and important mechanisms that control neurodegeneration. He has published over 150 articles and book chapters, with multiple patents that have been the foundation of three companies: ImmunArray, Alma Bio Therapeutics and AnTolRx. Dr Quintana is a recipient of the Lady Anne Chain Prize for Academic Excellence and Scientific Achievements, the Junior Investigator Award from the National Multiple Sclerosis Society, the Pathway to Independence Award of the National Institute of Allergy and Infectious Diseases, the Award for Outstanding Research Achievement from Nature Biotechnology, the Tecan Award for Innovation, the Harry Weaver Award from the National Multiple Sclerosis Society, the Mentor Award from Harvard Medical School, the Milestones in Multiple Sclerosis Research Award from the National Multiple Sclerosis Society, the American Association of Immunologists-BD Biosciences Investigator Award and the Barancik Prize of Innovation in Multiple Sclerosis Research. Dr Quintana is a University of Buenos Aires graduate, has an immunology Ph.D. from the Weizmann Institute of Science and did postdoctoral training at the Weizmann Institute and Harvard Medical School before joining the faculty at Harvard in 2009.